Biogen (BIIB) Debt to Equity (2016 - 2025)
Biogen (BIIB) has 16 years of Debt to Equity data on record, last reported at $0.01 in Q2 2025.
- For Q2 2025, Debt to Equity changed N/A year-over-year to $0.01; the TTM value through Jun 2025 reached $0.01, changed N/A, while the annual FY2024 figure was $0.27, 41.98% down from the prior year.
- Debt to Equity reached $0.01 in Q2 2025 per BIIB's latest filing, down from $0.27 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.47 in Q4 2022 and bottomed at $0.01 in Q2 2025.
- Average Debt to Equity over 5 years is $0.26, with a median of $0.27 recorded in 2024.
- Peak YoY movement for Debt to Equity: skyrocketed 414.62% in 2022, then tumbled 41.98% in 2024.
- A 5-year view of Debt to Equity shows it stood at $0.09 in 2021, then surged by 414.62% to $0.47 in 2022, then dropped by 0.07% to $0.47 in 2023, then plummeted by 41.98% to $0.27 in 2024, then crashed by 96.87% to $0.01 in 2025.
- Per Business Quant database, its latest 3 readings for Debt to Equity were $0.01 in Q2 2025, $0.27 in Q4 2024, and $0.47 in Q4 2023.